The Food and Drug Administration has approved an implant that may help those addicted to opioids. The new medication called Probuphine is inserted in four rods in the addicted. Experts indicate that the implants, which administer a constant low-level dose of medication, would stop opioid cravings for injured workers. The implants are projected to last at least six months.
Given the scourge of opioid addiction following many serious worker’s compensation injuries, the FDA’s approval of the implants is welcome news for injured workers.